FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...